FGFR2-Rearranged Cholangiocarcinoma Highlights the Need for Precision Trial Design
Cholangiocarcinoma, a cancer arising in the bile ducts, has become an unexpected test of whether precision oncology can deliver on ...
Cholangiocarcinoma, a cancer arising in the bile ducts, has become an unexpected test of whether precision oncology can deliver on ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine